TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

NCT07720843 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Relapse Multiple Myeloma
Refractory Multiple Myeloma

Interventions

DRUG: Talquetamab
DRUG: Belantamab mafodotin
DRUG: Pomalidomide

Sponsor

Montefiore Medical Center

Collaborators

[object Object]